Molecular diagnostics allows for a flexible, reliable, and affordable profiling of a patient’s sensitization status.

We work with an allergen panel comprised of 117 allergen extracts and 178 molecular allergens, which makes it the largest panel of molecular allergens on the IgE allergy testing market. The use of molecular allergens leads to a much more precise risk assessment (e.g., the risk of anaphylaxis in a patient), a complete resolution of possible cross-reactivites, indication for immunotherapy, as well as differentiated dietary recommendations. 

So why do we use both allergen extracts AND molecular allergens? We use allergen extracts where molecular allergens are not yet well-characterized or redundant due to a high degree of cross-reactivity. In return, we use molecular allergens where allergen extracts are unstable. This combination assures the most accurate profiling of a patient’s sensitizationSensitization is the first step towards developing a type I allergy. Allergic reactions do not occur upon first contact with an allergen. Before that can happen, your immune system must be able to recognize an allergen. When you get stung by a bee, your immune system will remember the structure of the allergen (= a protein in the insect venom) to be able to produce IgE antibodies against it in the future. This process is called sensitization. status.

Once the lab report is uploaded to the secure 7DROPS platform, patients can consult with their allergy specialist or nutritionist to come up with individualized therapeutic measures.

Examples for therapeutic measures include avoiding the allergen or food antigen, individualized medication, or allergen-specific immunotherapy to improve their health and quality of life.